<DOC>
	<DOCNO>NCT01836874</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness topiramate prevent migraine among Indian participant require prophylaxis ( measure take maintain health prevent spread disease ) .</brief_summary>
	<brief_title>A Study Prophylaxis Migraine Patients With Topiramate India</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , multi-center ( study conduct multiple site ) study . In study approximately 209 participant observe . Participants receive topiramate observe monthly 3 month . Safety assessment include evaluation adverse event body weight participant monitor throughout study . The total duration study approximately 3 month .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Participants experience migraine three time per month require prophylaxis medication Participants least 6 month migraine history ( diagnose per international headache society criterion without aura ) Other indication migraine prophylaxis : use acute treatment medication frequently ( 2 treatment day per week ) ; increase frequency headache nonresponsive acute therapy ; require rescue therapy month Participants see benefit topiramate base upon physician 's judgment Headaches migraine episodic tension sinus headache headache exceed 15 day per month Onset migraine age 50 An exclusively migraine aura without headache painful condition migraine pain Having significant history unstable medical disease At risk term contraindication product insert topiramate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Indian</keyword>
	<keyword>Topiramate</keyword>
</DOC>